All In Biotech

Drug Trial Radar · NCT05006885

ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)

A Phase 1, 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease

Last checked: Nov 19, 2026Latest source record: Jul 27, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

95

Actual

Start

Sep 30, 2021

Primary completion

Aug 17, 2022

Study completion Aug 17, 2022

Sponsor

Lead sponsor
Altimmune, Inc.Industry
Sponsor type
Industry
First posted
Aug 16, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to assess the safety and tolerability of ALT-801 in diabetic and non-diabetic subjects with overweight and obese and non-alcoholic fatty liver disease (NAFLD).

Conditions

  • Non-Alcoholic Fatty Liver Disease

Interventions

  • ALT-801Drug

    Injected subcutaneously (SC)

  • PlaceboOther

    Injected subcutaneously (SC)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Number of Participants with One or More Treatment-Emergent Adverse Events (TEAEs)Time frame: Up to Day 110

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Headlands Research Scottsdale

    Scottsdale, Arizona

  • QLMC

    Tucson, Arizona

  • Catalina Research Institute

    Montclair, California

  • Clinical Trials Research

    Sacramento, California

  • Panax Clinical Research

    Miami Lakes, Florida

  • Covenant Research and Clinics

    Sarasota, Florida

  • Headlands Research Sarasota

    Sarasota, Florida

  • Wake Research CRCN

    Las Vegas, Nevada

  • Accelemed Research Institute

    Austin, Texas

  • Pinnacle Research

    Austin, Texas

  • South Texas Research Institute

    Brownsville, Texas

  • South Texas Research Institute

    Edinburg, Texas

  • Diagnostics Research Group

    San Antonio, Texas

  • Pinnacle Research

    San Antonio, Texas

  • Cognitive Clinical Trials

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.